Vor Bio (VOR) announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. Dr. Osovsky joins Vor Bio from iTeos Therapeutics (ITOS), where she served as Executive Vice President, Head of Legal & Corporate Secretary.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOR:
- Vor Biopharma Appoints Sarah Reed to Board
- Vor Biopharma Files Prospectus for $119.7M Stock Sale
- Vor Bio’s telitacicept achieved primary endpoint in Phase 3 study
- Largest borrow rate increases among liquid names
- Positive Phase 3 Results and Strong Financial Position Support Buy Rating for Vor Biopharma